ArticleJournal for immunotherapy of cancer2026

Adjuvant chemo-immunotherapy shows comparable efficacy among mismatch-repair-deficient and mismatch-repair-proficient stage III colon cancer: an exploratory, reconstructed individual patient-level data analysis.

Yu-Tong Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.